Abstract
Trauma is one of the most serious health care problems in the United States. It is the leading cause of mortality in the 1–40 year age group with more than 50 million injuries per year. In 1982 alone there were over 165 000 trauma deaths resulting in an economic impact of more than $88 billion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Walker RI (1984) The pathophysiology of combined injury and trauma. In: Walker RI, Gruber DF, MacVittie TJ, Conklin JJ (eds) The pathophysiology of combined injury and trauma. Bethesda, Armed Forces Radiobiology Research Institute, pp 3–8
Warden GD, Mason AD, Pruit BA (1974) Evaluation of leukocyte Chemotaxis in vitro in thermally injured patients. J Clin Invest 54: 1001–1004
Constantian MB, Menzoian JO, Nimberg RB et al. (1977) Association of a circulating immunosuppressive polypeptide with operative and accidental trauma. Ann Surg 185: 73–79
Hakim AA (1977) An immunosuppressive factor from serum of thermally traumatized patients. J Trauma 17: 908–919
Christou NV, Meakins JL (1983) Partial analysis and purification of polymorphonuclear neutrophil chemotactic inhibitors in serum from anergic patients. Arch Surg 118: 156–160
Ozkan AN, Ninnemann JL (1985) Circulating mediators in thermal injuries: isolation and characterization of a burn-injury induced immunosuppressive serum component. J Burn Care Rehabil 6: 147–151
Ozkan AN, Ninnemann JL (1985) Suppression of in vitro lymphocyte and neutrophil responses by a low molecular weight suppressor active peptide from burn patient sera. J Clin Immunol 5: 221–228
Ozkan AN, Ninnemann JL (1986) Progress in the characterization of an immunosuppressive glycopeptide from patients with major thermal injuries. J Burn Care Rehabil 7: 388–397
Ozkan AN, Ninnemann JL (1987) Reversal of suppressor active peptide induced immunosuppression and SAP detection by a monoclonal antibody. J Trauma 27: 123–126
Krzystyniak K, Stacharska J, Ryzewski K et al. (1978) Suppressive effect of low molecular weight fibrinogen degradation products on human and rat lymphocytes. Thromb Res 12: 523–530
Edgington TS, Curtiss LK, Plow EF (1985) A linkage between the hemostatic and immune systems embodied in the fibrinolytic release of lymphocyte suppressive peptide. J Immunol 134: 471–477
Plow EF, Edgington TS (1986) Lymphocyte suppressive peptides from fibrinogen are derived predominantly from the A alpha chain. J Immunol 137: 1910–1915
Ehrlich MI, Krushell JS, Blumenstock FA et al. (1981) Depression of phagocytosis by plasmin degradation products of plasma fibronectin. J Lab Clin Med 98: 263–271
Easter DW, Hoyt DB, Ozkan AN (1988) Immunosuppression by a peptide from the gelatin binding domain of human fibronectin. J Surg Res (in press)
Hoyt DB, Ozkan AN, Easter DW (1988) Isolation of an immunosuppressive trauma peptide and its relationship to fibronectin. J Trauma 28: 1–7
Dayer JM, Trentham DE, Krane SM (1982) Collagens act as ligands to stimulate human monocytes to produce mononuclear cell factor and prostaglandins. Coll Relat Res 2: 523–540
Ozkan AN, Ninnemann JL (1985) Burn-associated suppressor active peptide: relationship to tissue collagen. Proc Am Burn Assoc 15: 50
Clowes GH, George BC, Villee CA et al. (1983) Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med 308: 545–552
Ozkan AN, Hoyt DB, Mitchell MD et al. (1988) Trauma peptide mediated prostaglandin E2 biosynthesis: a potential mechanism for trauma-induced immunosuppression. Immunol Lett 17: 79–83
Rodrick ML, Wood JJ, O’Mahony JB et al. (1986) Mechanisms of immunosuppression associated with severe nonthermal traumatic injuries in man. Production of interleukin-1 and -2. J Clin Immunol 6: 310–318
Wood JJ, O’Mahony JB, Rodrick ML et al. (1986) Abnormalities of antibody production after thermal injury: an association with reduced interleukin 2 production. Arch Surg 121: 108–115
Tompkins SD, Gregory S, Hoyt DB et al. (1988) Inhibition of IL-2 biosynthesis by a trauma-induced glycopeptide. FASEB J 2: 8978
Pinney E, Hoyt DB, Ozkan AN (1988) The effect of a trauma-induced immunosuppressive peptide on phorbol ester activated T lymphocyte. FASEB J 2: 8974
Colombani PM, Robb A, Hess AD (1985) Cyclosporin a binding to calmodulin: a possible site of action on T lymphocytes. Science 19: 337–339
Le Grue SJ, Munn CG (1986) Comparison of the immunosuppressive effects of cyclosporin, lipid soluble anesthetics and calmodulin antagonists. Transplantation 42: 679–685
Ozkan AN, Hoyt DB, Ninnemann JL (1987) Generation and activity of suppressor peptides following traumatic injury. J Burn Care Rehabil 8: 527–530
Ozkan AN, Pinney E, Hoyt DB et al. (1988) Protease and suppressor active peptide activity following burn injury. J Trauma (in press)
Mary D, Aussel C, Ferrua B et al. (1987) Regulation of interleukin 2 synthesis by cAMP in human T cells. J Immunol 139: 1179–1184
Imboden JB (1988) The regulation of intracellular signals during lymphocyte activation. Immunol Today 9: 17–18
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag, Berlin Heidelberg
About this paper
Cite this paper
Ozkan, A.N. (1989). Serum Mediators and the Generation of Immune Suppression. In: Faist, E., Ninnemann, J.L., Green, D.R. (eds) Immune Consequences of Trauma, Shock, and Sepsis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73468-7_36
Download citation
DOI: https://doi.org/10.1007/978-3-642-73468-7_36
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73470-0
Online ISBN: 978-3-642-73468-7
eBook Packages: Springer Book Archive